Definium Therapeutics, Inc. (DFTX): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$131.56M
Year ended 2025-12-31
-$167.95M
Trailing 12 months to 2026-06-30
2020-12-31: -$23.60M2021-12-31: -$45.82M2022-12-31: -$50.14M2023-12-31: -$64.36M2024-12-31: -$79.13M2025-12-31: -$131.56M-$131.56M
2020-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$131.56Mn/m2026-02-26, From 2025-01-01
2024-12-31-$79.13Mn/m2026-02-26, From 2024-01-01
2023-12-31-$64.36Mn/m2025-03-06, From 2023-01-01
2022-12-31-$50.14Mn/m2024-02-28, From 2022-01-01
2021-12-31-$45.82Mn/m2023-03-09, From 2021-01-01
2020-12-31-$23.60Mn/a2022-03-28, From 2020-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Definium Therapeutics, Inc. (DFTX)2025-12-31-$131.56Mn/m
Jushi Holdings Inc. (JUSH)2025-12-31$17.73M-17.8%
Glass House Brands Inc. (GLAS)2025-12-31$11.45M-59.7%
USANA Health Sciences Inc (USNA)2026-01-03$22.35M-63.4%
Ascend Wellness Holdings, Inc. (AAWH)2025-12-31$38.05M-48.1%
Marimed Inc. (MRMD)2025-12-31$7.70M+13.4%
Cronos Group Inc. (CRON)2025-12-31$25.87M+37.3%
Cresco Labs Inc. (CRLBF)2025-12-31$72.89M-45.0%
Natural Alternatives International Inc (NAII)2026-06-30-$8.92Mn/m

Compare DFTX, JUSH, GLAS, USNA side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗